Patents by Inventor Jianjun ZOU

Jianjun ZOU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF COMPOSITION CONTAINING CDK4/6 INHIBITOR IN COMBINATION WITH ANASTROZOLE IN PREPARATION OF MEDICAMENT FOR TREATING TUMOR DISEASES
    Publication number: 20220125792
    Abstract: The present disclosure relates to use of a composition containing a CDK4/6 inhibitor in combination with anastrozole in preparation of a medicament for treating tumor diseases. Specifically, the CDK4/6 inhibitor involved in the application is a compound represented by formula (I) or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: January 22, 2020
    Publication date: April 28, 2022
    Applicant: Jiangsu Hengrui Medicine Co., Ltd.
    Inventors: Xiaoyu ZHU, Guorong LI, Jianjun ZOU
  • USE OF IL-15 PROTEIN COMPLEX JOINT PD-L1 ANTIBODY FOR TREATING TUMOR DISEASES
    Publication number: 20220111008
    Abstract: Provided is use of IL-15 protein complex joint PD-L1 antibody for treating tumor diseases.
    Type: Application
    Filed: December 12, 2019
    Publication date: April 14, 2022
    Inventors: Xing Sun, Chen Ma, Changyong Yang, Cheng Liao, Lianshan Zhang, Jianjun Zou, Wei Shi, Yuanyuan Du, Yujie Zhou
  • Use of combination of VEGFR inhibitor and PARP inhibitor in preparation of medicament for treating gastric cancer
    Patent number: 11000518
    Abstract: A combination of a VEGFR inhibitor and a PARP inhibitor is described. In particular, this combination can be used in the preparation of a medicament for treating gastric cancer.
    Type: Grant
    Filed: November 30, 2017
    Date of Patent: May 11, 2021
    Assignee: Jiangsu Hengrui Medicine Co., Ltd.
    Inventors: Jiahua Jiang, Guoqing Cao, Changyong Yang, Lianshan Zhang, Jianjun Zou, Piaoyang Sun
  • USES OF EGFR/HER2 INHIBITOR COMBINED WITH PYRIMIDINE-TYPE ANTI-METABOLIC DRUG
    Publication number: 20190358212
    Abstract: Uses of an EGFR/HER2 inhibitor combined with a pyrimidine-type anti-metabolic drug are provided. Specifically, uses of an EGFR/HER2 receptor tyrosine kinase inhibitor combined with pyrimidine-type anti-metabolic drug in the preparation of drugs for treating cancers are provided.
    Type: Application
    Filed: January 19, 2018
    Publication date: November 28, 2019
    Inventors: Jianjun ZOU, Guoqing CAO, Xiaoyu ZHU
  • USE OF COMBINATION OF VEGFR INHIBITOR AND PARP INHIBITOR IN PREPARATION OF MEDICAMENT FOR TREATING GASTRIC CANCER
    Publication number: 20190275021
    Abstract: A combination of a VEGFR inhibitor and a PARP inhibitor is described. In particular, this combination can be used in the preparation of a medicament for treating gastric cancer.
    Type: Application
    Filed: November 30, 2017
    Publication date: September 12, 2019
    Applicants: Jiangsu Hengrui Medicine Co., Ltd., Jiangsu Hengrui Medicine Co., Ltd.
    Inventors: Jiahua JIANG, Guoqing CAO, Changyong YANG, Lianshan ZHANG, Jianjun ZOU, Piaoyang SUN
  • USE OF TYROSINE-KINASE INHIBITOR IN PREPARING PHARMACEUTICAL PRODUCT FOR CANCER TREATMENT
    Publication number: 20190224189
    Abstract: Provided is a method of treating cancer with a tyrosine-kinase inhibitor. In particular, provided is a method of treating cancer containing a mutated epidermal growth factor receptor (EGFR) with compound A, or a pharmaceutically acceptable salt thereof, preferably a maleate or dimaleate salt of compound A.
    Type: Application
    Filed: September 22, 2017
    Publication date: July 25, 2019
    Inventors: Jianjun ZOU, Yaling HUANG, Tonghuan HU, Xiaoyu ZHU, Jun FENG, Changyong YANG, Chen ZONG, Guoqing CAO
  • SKIN TEXTURE COLLECTION AND IDENTITY RECOGNITION METHOD AND SYSTEM
    Publication number: 20160300094
    Abstract: This application discloses a skin texture collection and identity recognition method. The method includes: collecting a skin texture image of a user; determining a quality weighted value of the skin texture image; comparing the skin texture image with a preset template image to determine a skin texture comparison value; multiplying the quality weighted value by the skin texture comparison value to obtain a multiplication result; and judging whether the multiplication result is greater than a first preset value, and, if yes, than to determine that the identity of the user is to be legitimate. In the examples, due to the facts that minutiae do not need to be emphasized excessively, and texture and large joints are emphasized, the problem that login is rejected due to the lack of the minutiae is reduced.
    Type: Application
    Filed: March 14, 2014
    Publication date: October 13, 2016
    Inventors: Jie LU, Jianjun ZOU, Xuxiao HU, Shengguo WANG